Whether the immunomodulatory properties of SKLT could prevent bone loss in a disease setting was investigated in the inducible osteoporosis medaka model Tg(rankl:HSE: CFP)TG1135, in which bone resorption is triggered by conditional overexpression of RANKL (19). This evidence concerns the gene TNFSF11 and osteoporosis.